How many insider declarations has Smith Susan Laura filed?

Smith Susan Laura has filed 3 public insider declarations with SEC (Form 4).

What is Smith Susan Laura's role?

Smith Susan Laura's reported role is not specified by the regulator across the filings.

Which companies does Smith Susan Laura report trades for?

Smith Susan Laura reports trades for Y-mAbs Therapeutics, Inc..

What is Smith Susan Laura's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 26k€.

← Executives ★ Sign in to follow

SS

Smith Susan Laura

·SEC (Form 4)

Y-mAbs Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€25,644

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Smith Susan Laura. Director active across 1 company, notably Y-mAbs Therapeutics, Inc.. In total, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €26k. Activity tracked since 17 January 2023. The latest transaction was disclosed on 5 March 2024 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Smith Susan Laura

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Y-mAbs Therapeutics, Inc. (US)

申报3 总计

▼

Smith Susan Laura

SVP & CHIEF COMMERCIAL OFFICER高管2024年3月5日Y-mAbs Therapeutics, Inc.

US$27,83734SEC ↗

1,682 股@ US$16.55100.0% 占其流量Common StockSEC:0001104659-24-031939:0

◆

Smith Susan Laura

SVP & CHIEF COMMERCIAL OFFICER高管2024年1月18日Y-mAbs Therapeutics, Inc.

0SEC ↗

17,800 股0Common StockSEC:0001415889-24-001649:0

◆

Smith Susan Laura

SVP & CHIEF COMMERCIAL OFFICER高管2023年1月17日Y-mAbs Therapeutics, Inc.

0SEC ↗

17,800 股0Common StockSEC:0001104659-23-005033:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SS

Smith Susan Laura

·SEC (Form 4)

Y-mAbs Therapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€25,644

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Smith Susan Laura. Director active across 1 company, notably Y-mAbs Therapeutics, Inc.. In total, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €26k. Activity tracked since 17 January 2023. The latest transaction was disclosed on 5 March 2024 (Cession). Regulator: SEC (Form 4). All data is free.